[DOI] [PubMed] [Google Scholar] 23.Euston D.R., Gruber A.J., McNaughton B.L
Semaglutide is available in both injectable and oral forms, with the injectable form being more commonly used
Consult with healthcare providers about how semaglutide relates to your individual reproductive planning and pregnancy considerations
Using a 90-degree angle, pinching the skin, and using the right needle length reduces this risk significantly
The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), a phase 3 study involving 17,604 adults with overweight or obesity and pre-existing CVD but no diabetes, revealed that once-weekly subcutaneous semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% compared with placebo over a mean follow-up of 39.8 months, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke [48]